Warning: This security is no longer trading.
Sobi Successfully Completes Acquisition of Dova Pharmaceuticals
Dova Pharmaceuticals, Inc. (DOVA): Price and Financial Metrics
DOVA Price/Volume Stats
| Current price | $28.04 | 52-week high | $28.54 |
| Prev. close | $28.00 | 52-week low | $5.62 |
| Day low | $28.01 | Volume | 1,488,000 |
| Day high | $28.19 | Avg. volume | 357,062 |
| 50-day MA | $23.75 | Dividend yield | N/A |
| 200-day MA | $14.16 | Market Cap | 807.61M |
DOVA Stock Price Chart Interactive Chart >
Dova Pharmaceuticals, Inc. (DOVA) Company Bio
Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. The company was founded in 2016 and is based in Durham, North Carolina.
DOVA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...